Literature DB >> 24045400

Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.

David Paling1, Esben Thade Petersen2, Daniel J Tozer1, Daniel R Altmann3, Claudia A M Wheeler-Kingshott1, Raju Kapoor1, David H Miller1, Xavier Golay4.   

Abstract

Alterations in the overall cerebral hemodynamics have been reported in multiple sclerosis (MS); however, their cause and significance is unknown. While potential venous causes have been examined, arterial causes have not. In this study, a multiple delay time arterial spin labeling magnetic resonance imaging sequence at 3T was used to quantify the arterial hemodynamic parameter bolus arrival time (BAT) and cerebral blood flow (CBF) in normal-appearing white matter (NAWM) and deep gray matter in 33 controls and 35 patients with relapsing-remitting MS. Bolus arrival time was prolonged in MS in NAWM (1.0±0.2 versus 0.9±0.2 seconds, P=0.031) and deep gray matter (0.90±0.18 versus 0.80±0.14 seconds, P=0.001) and CBF was increased in NAWM (14±4 versus 10±2 mL/100 g/min, P=0.001). Prolonged BAT in NAWM (P=0.042) and deep gray matter (P=0.01) were associated with higher expanded disability status score. This study demonstrates alteration in cerebral arterial hemodynamics in MS. One possible cause may be widespread inflammation. Bolus arrival time was longer in patients with greater disability independent of atrophy and T2 lesion load, suggesting alterations in cerebral arterial hemodynamics may be a marker of clinically relevant pathology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24045400      PMCID: PMC3887342          DOI: 10.1038/jcbfm.2013.161

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  38 in total

1.  A validation framework for probabilistic maps using Heschl's gyrus as a model.

Authors:  Amir M Tahmasebi; Purang Abolmaesumi; Conor Wild; Ingrid S Johnsrude
Journal:  Neuroimage       Date:  2009-12-28       Impact factor: 6.556

2.  Brain perfusion abnormalities in patients with compromised venous outflow.

Authors:  Ribal S Darwish; Nana S Amiridze
Journal:  J Neurol       Date:  2011-02-19       Impact factor: 4.849

3.  The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study.

Authors:  Esben Thade Petersen; Kim Mouridsen; Xavier Golay
Journal:  Neuroimage       Date:  2009-08-04       Impact factor: 6.556

4.  Arterial transit time effects in pulsed arterial spin labeling CBF mapping: insight from a PET and MR study in normal human subjects.

Authors:  Maolin Qiu; R Paul Maguire; Jagriti Arora; Beata Planeta-Wilson; David Weinzimmer; Jinghua Wang; Yuenan Wang; Hyeonjin Kim; Nallakkandi Rajeevan; Yiyun Huang; Richard E Carson; R Todd Constable
Journal:  Magn Reson Med       Date:  2010-02       Impact factor: 4.668

5.  Systemic inflammatory response reactivates immune-mediated lesions in rat brain.

Authors:  Sébastien Serres; Daniel C Anthony; Yanyan Jiang; Kerry A Broom; Sandra J Campbell; Damian J Tyler; Sander I van Kasteren; Benjamin G Davis; Nicola R Sibson
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

6.  Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease.

Authors:  Takashi Yoshiura; Akio Hiwatashi; Tomoyuki Noguchi; Koji Yamashita; Yasumasa Ohyagi; Akira Monji; Eiki Nagao; Hironori Kamano; Osamu Togao; Hiroshi Honda
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

7.  Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis.

Authors:  Owain W Howell; Jon L Rundle; Anurag Garg; Masayuki Komada; Peter J Brophy; Richard Reynolds
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

10.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  29 in total

Review 1.  Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.

Authors:  Christian Enzinger; Frederik Barkhof; Olga Ciccarelli; Massimo Filippi; Ludwig Kappos; Maria A Rocca; Stefan Ropele; Àlex Rovira; Torben Schneider; Nicola de Stefano; Hugo Vrenken; Claudia Wheeler-Kingshott; Jens Wuerfel; Franz Fazekas
Journal:  Nat Rev Neurol       Date:  2015-11-03       Impact factor: 42.937

2.  Cerebral Vasoreactivity as an Indirect MRI Marker of White Matter Tracts Alterations in Multiple Sclerosis.

Authors:  Jeremy Deverdun; Arthur Coget; Xavier Ayrignac; Clarisse Carra-Dalliere; Alexandre Krainik; Aude Metzger; Pierre Labauge; Nicolas Menjot de Champfleur; Emmanuelle Le Bars
Journal:  Brain Topogr       Date:  2021-01-23       Impact factor: 3.020

3.  Impaired retinal microcirculation in multiple sclerosis.

Authors:  Hong Jiang; Silvia Delgado; Jia Tan; Che Liu; Kottil W Rammohan; Delia Cabrera DeBuc; Byron L Lam; William J Feuer; Jianhua Wang
Journal:  Mult Scler       Date:  2016-02-22       Impact factor: 6.312

4.  Brain perfusion by arterial spin labeling MRI in multiple sclerosis.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Rosaria Renna; Matilde Inglese
Journal:  J Neurol       Date:  2015-05-28       Impact factor: 4.849

5.  Regional cerebral arterial transit time hemodynamics correlate with vascular risk factors and cognitive function in men with coronary artery disease.

Authors:  B J MacIntosh; W Swardfager; A D Robertson; E Tchistiakova; M Saleem; P I Oh; N Herrmann; B Stefanovic; K L Lanctôt
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-21       Impact factor: 3.825

Review 6.  Arterial spin labeling for the measurement of cerebral perfusion and angiography.

Authors:  Peter Jezzard; Michael A Chappell; Thomas W Okell
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-23       Impact factor: 6.200

7.  Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study.

Authors:  Olga Marshall; Sanjeev Chawla; Hanzhang Lu; Louise Pape; Yulin Ge
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-15       Impact factor: 6.200

8.  Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease.

Authors:  Xueling Suo; Du Lei; Lan Cheng; Nannan Li; Panli Zuo; Danny J J Wang; Xiaoqi Huang; Su Lui; Graham J Kemp; Rong Peng; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2018-12-07       Impact factor: 5.038

9.  The spatial coefficient of variation in arterial spin labeling cerebral blood flow images.

Authors:  Henri Jmm Mutsaerts; Jan Petr; Lena Václavů; Jan W van Dalen; Andrew D Robertson; Matthan W Caan; Mario Masellis; Aart J Nederveen; Edo Richard; Bradley J MacIntosh
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-06       Impact factor: 6.200

10.  Structural and physiological neurovascular changes in idiopathic Parkinson's disease and its clinical phenotypes.

Authors:  Sarah Al-Bachari; Rishma Vidyasagar; Hedley Ca Emsley; Laura M Parkes
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-23       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.